224
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Resource use decrease after implementation of care bundles for treatment of postpartum hemorrhage

ORCID Icon, , , , , ORCID Icon, , , & ORCID Icon show all
Pages 7874-7881 | Received 24 Mar 2021, Accepted 30 May 2021, Published online: 10 Jun 2021

References

  • Kassebaum N, Steiner C, Murray CJL, et al. Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(20150497):1775–1812.
  • Say L, Chou D, Gemmill A, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2(6):323–333.
  • Souza JP, Gülmezoglu AM, Vogel J, et al. Moving beyond essential interventions for reduction of maternal mortality (the WHO Multicountry Survey on Maternal and Newborn Health): a cross-sectional study. Lancet. 2013;381(9879):1747–1755.
  • Maswime S, Buchmann E. A systematic review of maternal near miss and mortality due to postpartum hemorrhage. Int J Gynecol Obstet. 2017;137(1):1–7.
  • Sheldon WR, Blum J, Vogel JP, et al. Postpartum haemorrhage management, risks, and maternal outcomes: findings from the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG. 2014;121(Suppl. 1):5–13.
  • Institute for Healthcare Improvement. Evidence-based care bundles; 2020; [cited 2020 Jan 1]. Available from: https://www.ihi.org/Topics/Bundles/Pages/default.aspx
  • Institute for Healthcare Improvement. How-to guide: prevent obstetrical adverse events. Cambridge (MA): Institute for Healthcare Improvement; 2012; [cited 2020 Jan 1]. Available from: https://www.ihi.org/resources/Pages/Tools/HowtoGuidePreventObstetricalAdverseEvents.aspx; www.ihi.org
  • Main EK, Goffman D, Scavone BM, et al. National partnership for maternal safety consensus bundle on obstetric hemorrhage. J Midwifery Womens Health. 2015;60:458–464.
  • Main EK, Goffman D, Scavone BM, et al. National partnership for maternal safety. Obstet Gynecol. 2015;126(1):155–162.
  • Main EK, Goffman D, Scavone BM, et al. National partnership for maternal safety: consensus bundle on obstetric hemorrhage [published correction appears in Anesth Analg. 2019;129(6):e206]. Anesth Analg. 2015;121(1):142–148.
  • Einerson BD, Miller ES, Grobman WA. Does a postpartum hemorrhage patient safety program result in sustained changes in management and outcomes? Am J Obstet Gynecol. 2015;212(2):140–144.e1.
  • Shields LE, Wiesner S, Fulton J, et al. Comprehensive maternal hemorrhage protocols reduce the use of blood products and improve patient safety. Am J Obstet Gynecol. 2015;212(3):272–280.
  • Main EK, Cape V, Abreo A, et al. Reduction of severe maternal morbidity from hemorrhage using a state perinatal quality collaborative. Am J Obstet Gynecol. 2017;216(3):298.e1–298.e11.
  • Escobar MF, Füchtner CE, Carvajal JA, et al. Experience in the use of non-pneumatic anti-shock garment (NASG) in the management of postpartum haemorrhage with hypovolemic shock in the Fundación Valle Del Lili, Cali, Colombia. Reprod Health. 2017;14(1):2–9.
  • Escobar MF, Suso JP, Hincapié MA, et al. Experience of combined use of a Bakri uterine balloon and a non-pneumatic anti-shock garment in a university hospital in Colombia. Int J Gynecol Obstet. 2019;146(2):244–249.
  • Escobar MF, Fernández Pérez PA, Carvajal JA, et al. Impact of nonpneumatic antishock garment in the management of patients with hypoperfusion due to massive postpartum hemorrhage. J Matern Neonatal Med. 2020;33(18):3086–3090.
  • Bodenheimer T, Sinsky C. From triple to quadruple aim: care of the patient requires care of the provider. Ann Fam Med. 2014;12(6):573–576.
  • Acuerdo 256 de 2001. "Manual de Tarifas" de la Entidad Promotora de Salud del Seguro Social. Diario Oficial No. 44.662, 30 de diciembre de 2001. Press; 2001.
  • Hsiao WC, Braun P, Dunn D, et al. Resource-based relative values: an overview. JAMA. 1988;260(16):2347–2353.
  • Vlassoff M, Walke D, Shearer J, et al. Estimates of health care system costs of unsafe abortion in Africa and Latin America. Int Perspect Sex Reprod Health. 2009;35(3):114–121.
  • Thi Win Shwe A, Riewpaiboon A, Chaikledkaew U, et al. Treatment cost and costing model of obstetric complications at a hospital in Myanmar. PLOS One. 2019;14(3):1–14.
  • Liu S, Liston RM, Joseph KS, et al. Maternal mortality and severe morbidity associated with low-risk planned cesarean delivery versus planned vaginal delivery at term. Can Med Assoc J. 2007;176:455–460.
  • Marshall AL, Durani U, Bartley A, et al. The impact of postpartum hemorrhage on hospital length of stay and inpatient mortality: a National Inpatient Sample-based analysis. Am J Obstet Gynecol. 2017;217(3):344.e1–344.e6.
  • Maher-Griffiths C. Maternal quality outcomes and cost. Crit Care Nurs Clin North Am. 2019;31(2):177–193.
  • Shimkhada R, Solon O, Tamondong-Lachica D, et al. Misdiagnosis of obstetrical cases and the clinical and cost consequences to patients: a cross-sectional study of urban providers in the Philippines. Glob Health Action. 2016;9(1).
  • Pickering K, Gallos ID, Williams H, et al. Uterotonic drugs for the prevention of postpartum haemorrhage: a cost-effectiveness analysis. Pharmacoecon Open. 2019;3(2):163–176.
  • Sudhof LS, Shainker SA, Einerson BD. Tranexamic acid in the routine treatment of postpartum hemorrhage in the United States: a cost-effectiveness analysis. Am J Obstet Gynecol. 2019;221(3):275.e1–275.e12.
  • Castiel D, Bréchat PH, Benoît B, et al. Coût total des actes chirurgicaux dans la prise en charge des hémorragies de la délivrance. Gynecol Obstet Fertil. 2008;36(5):507–515.
  • Hunt TD, Guglielminotti J, Li G. Costs associated with anesthesia-related adverse events during labor and delivery in New York State, 2010. Anesth Analg. 2016;122:2007–2016.
  • Sutherland T, Downing J, Miller S, et al. Use of the non-pneumatic anti-shock garment (NASG) for life-threatening obstetric hemorrhage: a cost-effectiveness analysis in Egypt and Nigeria. PLOS One. 2013;8:e62282.
  • Downing J, El Ayadi A, Miller S, et al. Cost-effectiveness of the non-pneumatic anti-shock garment (NASG): evidence from a cluster randomized controlled trial in Zambia and Zimbabwe. BMC Health Serv Res. 2015;15(1):1–10.
  • Herrick T, Mvundura M, Burke TF, et al. A low-cost uterine balloon tamponade for management of postpartum hemorrhage: modeling the potential impact on maternal mortality and morbidity in sub-Saharan Africa. BMC Pregnancy Childbirth. 2017;17(1):1–6.
  • Mvundura M, Kokonya D, Abu-Haydar E, et al. Cost-effectiveness of condom uterine balloon tamponade to control severe postpartum hemorrhage in Kenya. Int J Gynecol Obstet. 2017;137:185–191.
  • Ministry of Health and Social Protection. Flowcharts for obstetric emergency care. Health Minister. Minist Salud; 2013. p. 1–32; [cited 2019 Dec 9]. Available from: https://idsn.gov.co/site/web2/images/documentos/sreproductiva/2014/diag_flujo_atobs.pdf
  • WHO. Local production for access to medical products: addressing the barriers and challenges in low- and middle-income countries. Vol. 154; 2012; [cited 2019 Dec 9]. Available from: https://www.who.int/phi/publications/local_production/en/%0Ahttp://www.who.int/medical_devices/1240EHT_final.pdf?ua=1
  • Jordan K, Butrick E, Yamey G, et al. Barriers and facilitators to scaling up the non-pneumatic anti-shock garment for treating obstetric hemorrhage: a qualitative study. PLOS One. 2016;11(3):e0150739.
  • Main EK, McCain CL, Morton CH, et al. Pregnancy-related mortality in California. Obstet Gynecol. 2015;125:938–947.
  • Main EK, Abreo A, McNulty J, et al. Measuring severe maternal morbidity: validation of potential measures. Am J Obstet Gynecol. 2016;214(5):643.e1–643.e10.
  • Mann S, Hollier LM, McKay K, et al. What we can do about maternal mortality-and how to do it quickly. N Engl J Med. 2018;379:1689–1691.
  • Althabe F, Therrien MNS, Pingray V, et al. Postpartum hemorrhage care bundles to improve adherence to guidelines: a WHO technical consultation. Int J Gynecol Obstet. 2020;148:290–299.
  • Love-Koh J, Griffin S, Kataika E, et al. Methods to promote equity in health resource allocation in low- and middle-income countries: an overview. Global Health. 2020;16:1–12.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.